Developmental and epigenetic regulation of the human TLR3 gene

Molecular Immunology

Volumn 46, Issue 1, 2008, Pages 27-36

  Porrás, Analia ^a   Kozar, Sarah ^a   Russanova, Valya ^a   Salpea, Paraskevi ^a   Hirai, Tazuko ^a   Sammons, Nicholas ^a   Mittal, Pooja ^a   Kim, Ji Young ^a   Ozato, Keiko ^a   Romero, Roberto ^a   Howard, Bruce H ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Chromatin; Development; Epigenetics; Innate immunity; Toll like receptors

Indexed keywords

CIS ACTING ELEMENT; DOUBLE STRANDED RNA; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3;

ADULT; ARTICLE; CELL DIFFERENTIATION; CHROMATIN; CONTROLLED STUDY; DENDRITIC CELL; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INNATE IMMUNITY; MONOCYTE; NEWBORN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; TRANSCRIPTION INITIATION; UMBILICAL CORD BLOOD;

ADULT; AGING; ALLELES; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENDRITIC CELLS; EPIGENESIS, GENETIC; FETAL BLOOD; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HETEROZYGOTE; HISTONES; HUMANS; INFANT, NEWBORN; POLY I-C; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; TOLL-LIKE RECEPTOR 3;

EID: 52949113474     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.06.030     Document Type: Article

References (42)

1. Adkins B., Leclerc C., and Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4 (2004) 553-564
2. Anguera M.C., Sun B.K., Xu N., and Lee J.T. X-chromosome kiss and tell: how the Xs go their separate ways. Cold Spring Harb. Symp. Quant. Biol. 71 (2006) 429-437
3. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., and Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 129 (2007) 823-837
4. Belmont J.W. Genetic control of X inactivation and processes leading to X-inactivation skewing. Am. J. Hum. Genet. 58 (1996) 1101-1108
5. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber S.L., and Lander E.S. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006) 315-326
6. Braidotti G. RNA-FISH to analyze allele-specific expression. Methods Mol. Biol. 181 (2001) 169-180
7. Burke L.J., Zhang R., Bartkuhn M., Tiwari V.K., Tavoosidana G., Kurukuti S., Weth C., Leers J., Galjart N., Ohlsson R., and Renkawitz R. CTCF binding and higher order chromatin structure of the H19 locus are maintained in mitotic chromatin. EMBO J. 24 (2005) 3291-3300
8. Chartrand P., Bertrand E., Singer R.H., and Long R.M. Sensitive and high-resolution detection of RNA in situ. Methods Enzymol. 318 (2000) 493-506
9. Clark D.A., Manuel J., Lee L., Chaouat G., Gorczynski R.M., and Levy G.A. Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA × DBA/2 mouse model. I. Synergistic effect of LPS and (TNF-alpha + IFN-gamma) on pregnancy loss. Am. J. Reprod. Immunol. 52 (2004) 370-378
10. De Wit D., Tonon S., Olislagers V., Goriely S., Boutriaux M., Goldman M., and Willems F. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J. Autoimmun. 21 (2003) 277-281
11. Fleer A., and Krediet T.G. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn. Neonatology 92 (2007) 145-157
12. Fraser P. Transcriptional control thrown for a loop. Curr. Opin. Genet. Dev. 16 (2006) 490-495
13. Godfrey K.M., Lillycrop K.A., Burdge G.C., Gluckman P.D., and Hanson M.A. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr. Res. 61 (2007) 5R-10R
14. Goldberg A.D., Allis C.D., and Bernstein E. Epigenetics: a landscape takes shape. Cell 128 (2007) 635-638
15. Goren A., Simchen G., Fibach E., Szabo P.E., Tanimoto K., Chakalova L., Pfeifer G.P., Fraser P.J., Engel J.D., and Cedar H. Fine tuning of globin gene expression by DNA methylation. PLoS ONE 1 (2006) e46
16. Goriely S., Van Lint C., Dadkhah R., Libin M., De Wit D., Demonte D., Willems F., and Goldman M. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J. Exp. Med. 199 (2004) 1011-1016
17. Knudsen G.P., Pedersen J., Klingenberg O., Lygren I., and Orstavik K.H. Increased skewing of X chromosome inactivation with age in both blood and buccal cells. Cytogenet. Genome Res. 116 (2007) 24-28
18. Lang K.S., Georgiev P., Recher M., Navarini A.A., Bergthaler A., Heikenwalder M., Harris N.L., Junt T., Odermatt B., Clavien P.A., Pircher H., Akira S., Hengartner H., and Zinkernagel R.M. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J. Clin. Invest. 116 (2006) 2456-2463
19. Lehner M., and Holter W. Endotoxin-free purification of monocytes for dendritic cell generation via discontinuous density gradient centrifugation based on diluted Ficoll-Paque Plus. Int. Arch. Allergy Immunol. 128 (2002) 73-76
20. Levsky J.M., and Singer R.H. Gene expression and the myth of the average cell. Trends Cell Biol. 13 (2003) 4-6
21. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7 (2007) 379-390
22. Levy O., Zarember K.A., Roy R.M., Cywes C., Godowski P.J., and Wessels M.R. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 173 (2004) 4627-4634
23. Lu B.Y., and Eissenberg J.C. Time out: developmental regulation of heterochromatic silencing in Drosophila. Cell Mol. Life Sci. 54 (1998) 50-59
24. Marahrens Y. X-inactivation by chromosomal pairing events. Genes Dev. 13 (1999) 2624-2632
25. Marodi L. Innate cellular immune responses in newborns. Clin. Immunol. 118 (2006) 137-144
26. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., Lee W., Mendenhall E., O'Donovan A., Presser A., Russ C., Xie X., Meissner A., Wernig M., Jaenisch R., Nusbaum C., Lander E.S., and Bernstein B.E. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007) 553-560
27. Ohm J.E., McGarvey K.M., Yu X., Cheng L., Schuebel K.E., Cope L., Mohammad H.P., Chen W., Daniel V.C., Yu W., Berman D.M., Jenuwein T., Pruitt K., Sharkis S.J., Watkins D.N., Herman J.G., and Baylin S.B. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 39 (2007) 237-242
28. Ozanne S.E., and Constancia M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 539-546
29. Pastinen T., Sladek R., Gurd S., Sammak A., Ge B., Lepage P., Lavergne K., Villeneuve A., Gaudin T., Brandstrom H., Beck A., Verner A., Kingsley J., Harmsen E., Labuda D., Morgan K., Vohl M.C., Naumova A.K., Sinnett D., and Hudson T.J. A survey of genetic and epigenetic variation affecting human gene expression. Physiol. Genomics 16 (2004) 184-193
30. Prehaud C., Megret F., Lafage M., and Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79 (2005) 12893-12904
31. Puck J.M., and Willard H.F. X inactivation in females with X-linked disease. N. Engl. J. Med. 338 (1998) 325-328
32. Rassoulzadegan M., Grandjean V., Gounon P., Vincent S., Gillot I., and Cuzin F. RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse. Nature 441 (2006) 469-474
33. Renshaw M., Rockwell J., Engleman C., Gewirtz A., Katz J., and Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J. Immunol. 169 (2002) 4697-4701
34. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., and Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129 (2007) 1311-1323
35. Rupon J.W., Wang S.Z., Gaensler K., Lloyd J., and Ginder G.D. Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6617-6622
36. Russanova V.R., Hirai T.H., and Howard B.H. Semirandom sampling to detect differentiation-related and age-related epigenome remodeling. J. Gerontol. A Biol. Sci. Med. Sci. 59 (2004) 1221-1233
37. Russanova V.R., Hirai T.H., Tchernov A.V., and Howard B.H. Mapping development-related and age-related chromatin remodeling by a high throughput ChIP-HPLC approach. J. Gerontol. A Biol. Sci. Med. Sci. 59 (2004) 1234-1243
38. Stamatoyannopoulos G., and Grosveld F. Hemoglobin switching. In: Stamatoyannopoulos G. (Ed). The Molecular Basis of Blood Diseases (2001), Saunders, Philadelphia 135-182
39. Thein S.L., and Craig J.E. Genetics of Hb F/F cell variance in adults and heterocellular hereditary persistence of fetal hemoglobin. Hemoglobin 22 (1998) 401-414
40. Visintin A., Mazzoni A., Spitzer J.H., Wyllie D.H., Dower S.K., and Segal D.M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166 (2001) 249-255
41. Yu M., Han H., Xiang P., Li Q., and Stamatoyannopoulos G. Autonomous silencing as well as competition controls gamma-globin gene expression during development. Mol. Cell. Biol. 26 (2006) 4775-4781
42. Zhang J., Wei H., Wu D., and Tian Z. Toll-like receptor 3 agonist induces impairment of uterine vascular remodeling and fetal losses in CBA x DBA/2 mice. J. Reprod. Immunol. 74 (2007) 61-67